시장보고서
상품코드
1824440

세계의 색소침착장애 치료 시장 보고서(2025년)

Pigmentation Disorders Treatment Global Market Report 2025

발행일: | 리서치사: The Business Research Company | 페이지 정보: 영문 250 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송일정은 문의해 주시기 바랍니다.

색소침착장애 치료 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 2029년에는 CAGR 8.3%로 91억 7,000만 달러로 성장할 것으로 예상됩니다. 예측 기간의 성장은 전달 시스템의 강화, 미생물 기반의 치료, 재생 의료의 채용, 원격 의료 서비스 증가, 유전자 치료, 생물 제제에 기인한다고 생각됩니다. 예측 기간의 주요 동향은 피부 건강 교육 프로그램, 생물학에 착상을 얻은 스킨 케어 솔루션, 비 침습적 치료법, 신경 화장품 및 심리 피부 과학, 법적 규제, 안전 기준 등이 있습니다.

향후 5년간의 성장률 8.3%라고 하는 예측은 전회의 예측으로부터 0.2%의 소폭 감소를 반영하고 있습니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향 때문입니다. 무역 마찰은 한국과 스페인에서 개발된 Q-스위치 레이저 및 국소 탈색소제의 가격을 상승시켜 미용 치료 지연과 피부과 진료 비용의 상승을 초래하여 미국의 피부과 의료에 지장을 초래할 수 있습니다. 또한 상호관세와 무역의 긴장과 한계 증가로 인한 세계경제와 무역에 대한 악영향으로 인해 그 영향이 더욱 광범위해질 것으로 보입니다.

색소 침착증 발생률 증가는 미래에 색소침착장애 치료 시장의 성장을 가속할 것으로 예측됩니다. 색소 침착증은 유전, 호르몬 변화, 햇빛에 노출, 또는 기초 의학적 문제를 포함한 다양한 요인에 의해 유발되는 피부, 모발, 또는 눈의 비정상적 또는 불균일한 착색을 초래하는 상태입니다. 이러한 질환에 대한 치료법은 외용제, 레이저 치료, 화학 필링, 마이크로다마 브레이젼 등 여러 가지 방법이 있으며, 이들 모두는 알비니즘, 간반, 백반, 색소 침착 등의 상태와 관련된 검은 반점, 반점, 불규칙한 피부의 색소 침착을 경감 또는 완화하는 것을 목표로 합니다. 예를 들어, 2024년 6월 미국에 본사를 둔 정부 간 조직인 유엔은 북미와 유럽에서는 1만 7,000명에서 2만명 중 1명꼴로 어떤 형태로든 알비니즘을 앓고 있다고 보고했습니다. 그러나 사하라 이남의 아프리카에서는 유병률이 더 높고 탄자니아에서는 1,400명 중 1명이 알비니즘으로 추정되고 있으며, 짐바브웨나 남부 아프리카의 특정 민족 집단에서는 1,000명 중 1명이라는 높은 유병률도 보고되고 있습니다. 그 결과, 색소침착증의 유병률 증가가 색소침착장애 치료 시장의 성장에 박차를 가하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

  • 세계의 색소침착장애 치료 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
  • 최종 이용 산업의 분석
  • 세계의 색소침착장애 치료 시장 : 성장률 분석
  • 세계의 색소침착장애 치료 시장 실적 : 규모와 성장, 2019-2024
  • 세계의 색소침착장애 치료 시장 예측 : 규모와 성장, 2024-2029, 2034F
  • 세계의 색소침착장애 치료 : 전체 시장 규모(TAM)

제6장 시장 세분화

  • 세계의 색소침착장애 치료 시장 : 치료유형별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
  • 국소 치료
  • 피부 박리
  • 케미컬 필링
  • 레이저 치료
  • 광선 요법
  • 기타 치료의 유형
  • 세계의 색소침착장애 치료 시장 : 약물별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
  • 칼시뉴린 억제제
  • 멜라노사이트 자극 호르몬
  • 기타 약물의 유형
  • 세계의 색소침착장애 치료 시장 : 증상유형별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
  • 알비노
  • 백반
  • 멜라스마
  • 염증 후 과다 색소 침착(PIH)
  • 기타 증상의 유형
  • 세계의 색소침착장애 치료 시장 : 투여 경로별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
  • 경구
  • 외용약
  • 기타 투여 경로
  • 세계의 색소침착장애 치료 시장 : 유통 채널별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
  • 피부과 클리닉
  • 미용 클리닉
  • 약국과 화장품점
  • 전자상거래
  • 기타 유통 채널
  • 세계의 색소침착장애 치료 시장 : 세분화 국소 치료(치료유형별), 분석과 예측, 2019-2024, 2024-2029F, 2034F
  • Corticosteroids
  • Retinoids
  • Hydroquinone
  • 세계의 색소침착장애 치료 시장 : 세분화 피부 박리(치료유형별), 분석과 예측, 2019-2024, 2024-2029F, 2034F
  • 미세박피술
  • 다이아몬드 칩 더마브레이션
  • 크리스탈 더마브레이션
  • 세계의 색소침착장애 치료 시장 : 세분화 케미컬 필링(치료 유형별), 분석과 예측, 2019-2024, 2024-2029F, 2034F
  • 표면 필링
  • 중간 깊이 필링
  • 깊은 필링
  • 세계의 색소침착장애 치료 시장 : 세분화 레이저 치료(치료유형별), 분석과 예측, 2019-2024, 2024-2029F, 2034F
  • 분수 레이저
  • Q스위치 레이저
  • 강력한 펄스광(IPL)
  • 세계의 색소침착장애 치료 시장 : 세분화 광선 요법(치료유형별), 분석과 예측, 2019-2024, 2024-2029F, 2034F
  • UVB 광선요법
  • 협대역 UVB 광선 요법
  • 세계의 색소침착장애 치료 시장 : 세분화 기타 치료 유형(치료유형별), 분석과 예측, 2019-2024, 2024-2029F, 2034F
  • 동결요법
  • 탈색요법
  • 마이크로니들링
  • 다혈소판 혈장(PRP) 요법

제7장 지역별/국가별 분석

  • 세계의 색소침착장애 치료 시장 : 지역별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
  • 세계의 색소침착장애 치료 시장 : 국가별, 분석과 예측, 2019-2024, 2024-2029F, 2034F

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

  • 색소침착장애 치료 시장 : 경쟁 구도
  • 색소침착장애 치료 시장 : 기업 프로파일
    • AbbVie Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
    • Novartis AG : 개요, 제품 및 서비스, 전략 및 재무 분석
    • Sanofi SA : 개요, 제품 및 서비스, 전략 및 재무 분석
    • Bristol-Myers Squibb : 개요, 제품 및 서비스, 전략 및 재무 분석
    • L'Oreal SA : 개요, 제품 및 서비스, 전략 및 재무 분석

제31장 기타 주요 기업 및 혁신 기업

  • Bausch Health Companies Inc.
  • Bayer AG
  • Strides Pharma Science Limited
  • Galderma SA
  • Incyte Corporation
  • Dr. Reddy's Laboratories Ltd.
  • Laboratories Pierre Fabre
  • Glenmark Pharmaceuticals Limited.
  • Dermavant Sciences Inc.
  • Lumenis Be Ltd.
  • Accord Healthcare
  • Obagi Medical Products Inc.
  • Fotona doo
  • Sesderma SL
  • DermaMed Solutions LLC.

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

  • 색소침착장애 치료 시장 2029 : 새로운 기회를 제공하는 국가
  • 색소침착장애 치료 시장 2029 : 새로운 기회를 제공하는 부문
  • 색소침착장애 치료 시장 2029 : 성장 전략
    • 시장 동향에 기초한 전략
    • 경쟁 전략

제36장 부록

SHW

Pigmentation disorder treatment involves various methods and procedures aimed at addressing and managing conditions that affect the skin's pigmentation. These treatments are designed to restore or balance skin pigmentation, reduce the appearance of dark spots or patches, and improve overall skin tone and appearance.

The main types of pigmentation disorder treatments include topical treatment, dermabrasion, chemical peels, laser treatment, phototherapy, and others. Topical treatments involve the application of medications or products directly to the skin's surface to address various skin conditions, including pigmentation disorders. The treatment of pigmentation disorders utilizes various drugs such as calcineurin inhibitors, melanocyte-stimulating hormones, and others to address conditions such as albinism, vitiligo, melasma, post-inflammatory hyperpigmentation (PIH), and more. These drugs can be administered through oral, topical, and other routes and are distributed through dermatology clinics, aesthetic clinics, drugstores and cosmetic stores, e-commerce platforms, and other channels.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The pigmentation disorders treatment research report is one of a series of new reports from The Business Research Company that provides pigmentation disorders treatment market statistics, including the pigmentation disorders treatment industry's global market size, regional shares, competitors with a pigmentation disorders treatment market share, detailed pigmentation disorders treatment market segments, market trends and opportunities, and any further data you may need to thrive in the pigmentation disorders treatment industry. This pigmentation disorders treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The pigmentation disorders treatment market size has grown strongly in recent years. It will grow from $6.17 billion in 2024 to $6.67 billion in 2025 at a compound annual growth rate (CAGR) of 8.0%. The growth in the historic period can be attributed to topical treatment development, dermatological advancements, sunscreen and sun protection, chemical exfoliation methods, consumer awareness, and education.

The pigmentation disorders treatment market size is expected to see strong growth in the next few years. It will grow to $9.17 billion in 2029 at a compound annual growth rate (CAGR) of 8.3%. The growth in the forecast period can be attributed to enhanced delivery systems, microbiome-based therapies, regenerative medicine adoption, rise in telemedicine services, gene therapy, and biologics. Major trends in the forecast period include skin health education programs, bio-inspired skincare solutions, non-invasive treatment modalities, neurocosmetics and psychodermatology, legal regulations, and safety standards.

The forecast of 8.3% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. dermatological care by inflating prices of Q-switched lasers and topical depigmenting agents developed in South Korea and Spain, resulting in delayed cosmetic treatments and higher dermatology practice costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rising incidence of pigmentation disorders is anticipated to drive the growth of the pigmentation disorder treatment market in the future. Pigmentation disorders are conditions that result in abnormal or uneven coloration of the skin, hair, or eyes, caused by various factors including genetics, hormonal changes, sun exposure, or underlying medical issues. Treatment options for these disorders encompass several methods, such as topical medications, laser therapy, chemical peels, and microdermabrasion, all aimed at reducing or lightening dark spots, patches, or irregular skin pigmentation associated with conditions like albinism, melasma, vitiligo, or hyperpigmentation. For instance, in June 2024, the United Nations, a US-based intergovernmental organization, reported that in North America and Europe, about 1 in every 17,000 to 20,000 individuals is affected by some form of albinism. However, the prevalence is much higher in sub-Saharan Africa, with estimates indicating that 1 in 1,400 people in Tanzania have albinism, and some populations in Zimbabwe and specific ethnic groups in Southern Africa report rates as high as 1 in 1,000. Consequently, the increasing prevalence of pigmentation disorders is fueling the growth of the pigmentation disorders treatment market.

The substantial growth of disposable incomes worldwide is a significant contributor to the expansion of the pigmentation disorder treatment market. Rising disposable incomes, particularly in developing regions, empower individuals to allocate more resources to cosmetic and dermatological treatments. Data from October 2023 published by the Bureau of Economic Analysis revealed an increase in Americans' disposable income from $18,247.8 billion in the first quarter of 2022 to $19,880.2 billion in the first quarter of 2023. Consequently, the global rise in disposable incomes is expected to drive the pigmentation disorders treatment market.

A noteworthy trend in the pigmentation disorder treatment market is the integration of technological advancements. Major companies in this market are focusing on developing innovative products utilizing advanced technologies to enhance their market position. For instance, Scientis SA introduced the Cyspera Intensive System in March 2022, a comprehensive solution leveraging dual chamber technology. This system incorporates key ingredients such as Cysteamine Isobionic-Amid Complex, AHA-Amino Acid Complex, and Isobionic-Amide Complex, effectively addressing hyperpigmentation by delivering potent antioxidant activity, balancing skin pH, and providing anti-inflammatory benefits.

Companies operating in the pigmentation disorder treatment market are also placing emphasis on the development of nutricosmetics products. The integration of nutricosmetics involves using oral supplements to improve skin health and is gaining popularity. Nutrients such as antioxidants and vitamins are promoted for their potential benefits to pigmentation and overall skin condition. For instance, in March 2023, Symrise AG launched diana food bioactives, a collection of innovative nutricosmetic ingredients designed for 'Beauty from within' products. The collection includes solutions for skin conditioning, anti-aging, skin brightening, and hair and nail care, contributing to the expanding field of cosmetic ingredients.

In February 2024, Shiseido, a Japan-based cosmetics company, acquired DDG Skincare Holdings LLC for an undisclosed sum. This strategic acquisition aligns with Shiseido's goal to enhance its portfolio with scientifically validated skincare solutions. Dr. Dennis Gross Skincare is a US-based provider of treatments for pigmentation disorders.

Major companies operating in the pigmentation disorders treatment market include AbbVie Inc., Novartis AG, Sanofi S.A., Bristol-Myers Squibb, L'Oreal S.A., Bausch Health Companies Inc., Bayer AG, Strides Pharma Science Limited, Galderma S.A., Incyte Corporation, Dr. Reddy's Laboratories Ltd., Laboratories Pierre Fabre, Glenmark Pharmaceuticals Limited., Dermavant Sciences Inc., Lumenis Be Ltd., Accord Healthcare, Obagi Medical Products Inc., Fotona d.o.o., Sesderma SL, DermaMed Solutions LLC., Vital Esthetique, Vivier Pharma, Arcutis Biotherapeutics, Episciences Inc., Phio Pharmaceuticals Inc., Scientis SA, Philadelphia Pharmaceutical

North America was the largest region in the pigmentation disorders treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pigmentation disorders treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the pigmentation disorders treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pigmentation disorders treatment market consists of revenues earned by entities by providing pigmentation disorders treatment services such as cryotherapy, light therapy, and depigmentation. The market value includes the value of related goods sold by the service provider or included within the service offering. The pigmentation disorder treatment market also includes sales of topical creams and serums, micro needling devices, and light therapy devices that are used in pigmentation disorder treatments. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pigmentation Disorders Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pigmentation disorders treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pigmentation disorders treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The pigmentation disorders treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Treatment Type: Topical Treatment; Dermabrasion; Chemical Peels; Laser Treatment; Phototherapy; Other Treatment Types
  • 2) By Drugs: Calcineurin Inhibitors; Melanocyte-Stimulating Hormone; Other Drug Types
  • 3) By Type Of Disorder: Albinism; Vitiligo; Melasma; Post-Inflammatory Hyperpigmentation (PIH); Other Types Of Disorder
  • 4) By Route Of Administration: Oral; Topical; Other Routes Of Administration
  • 5) By Distribution Channel: Dermatology Clinics; Aesthetic Clinics; Drugstores And Cosmetic Stores; E-Commerce; Other Distribution Channels
  • Subsegments:
  • 1) By Topical Treatment: Corticosteroids; Retinoids; Hydroquinone
  • 2) By Dermabrasion: Microdermabrasion; Diamond Tip Dermabrasion; Crystal Dermabrasion
  • 3) By Chemical Peels: Superficial Peels; Medium Peels; Deep Peels
  • 4) By Laser Treatment: Fractional Lasers; Q-Switched Lasers; Intense Pulsed Light (IPL)
  • 5) By Phototherapy: UVB Phototherapy; Narrowband UVB Phototherapy
  • 6) By Other Treatment Types: Cryotherapy; Depigmentation Therapy; Microneedling; Platelet-Rich Plasma (PRP) Therapy
  • Companies Mentioned: AbbVie Inc.; Novartis AG; Sanofi S.A.; Bristol-Myers Squibb; L'Oreal S.A.; Bausch Health Companies Inc.; Bayer AG; Strides Pharma Science Limited; Galderma S.A.; Incyte Corporation; Dr. Reddy's Laboratories Ltd.; Laboratories Pierre Fabre; Glenmark Pharmaceuticals Limited.; Dermavant Sciences Inc.; Lumenis Be Ltd.; Accord Healthcare; Obagi Medical Products Inc.; Fotona d.o.o.; Sesderma SL; DermaMed Solutions LLC.; Vital Esthetique; Vivier Pharma; Arcutis Biotherapeutics; Episciences Inc.; Phio Pharmaceuticals Inc.; Scientis SA; Philadelphia Pharmaceutical
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Pigmentation Disorders Treatment Market Characteristics

3. Pigmentation Disorders Treatment Market Trends And Strategies

4. Pigmentation Disorders Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Pigmentation Disorders Treatment Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Pigmentation Disorders Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Pigmentation Disorders Treatment Market Growth Rate Analysis
  • 5.4. Global Pigmentation Disorders Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Pigmentation Disorders Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Pigmentation Disorders Treatment Total Addressable Market (TAM)

6. Pigmentation Disorders Treatment Market Segmentation

  • 6.1. Global Pigmentation Disorders Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Topical Treatment
  • Dermabrasion
  • Chemical Peels
  • Laser Treatment
  • Phototherapy
  • Other Treatment Types
  • 6.2. Global Pigmentation Disorders Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Calcineurin Inhibitors
  • Melanocyte-Stimulating Hormone
  • Other Drug Types
  • 6.3. Global Pigmentation Disorders Treatment Market, Segmentation By Type Of Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Albinism
  • Vitiligo
  • Melasma
  • Post-Inflammatory Hyperpigmentation (PIH)
  • Other Types Of Disorder
  • 6.4. Global Pigmentation Disorders Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Oral
  • Topical
  • Other Routes Of Administration
  • 6.5. Global Pigmentation Disorders Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Dermatology Clinics
  • Aesthetic Clinics
  • Drugstores And Cosmetic Stores
  • E-Commerce
  • Other Distribution Channels
  • 6.6. Global Pigmentation Disorders Treatment Market, Sub-Segmentation Of Topical Treatment, By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Corticosteroids
  • Retinoids
  • Hydroquinone
  • 6.7. Global Pigmentation Disorders Treatment Market, Sub-Segmentation Of Dermabrasion, By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Microdermabrasion
  • Diamond Tip Dermabrasion
  • Crystal Dermabrasion
  • 6.8. Global Pigmentation Disorders Treatment Market, Sub-Segmentation Of Chemical Peels, By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Superficial Peels
  • Medium Peels
  • Deep Peels
  • 6.9. Global Pigmentation Disorders Treatment Market, Sub-Segmentation Of Laser Treatment, By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Fractional Lasers
  • Q-Switched Lasers
  • Intense Pulsed Light (IPL)
  • 6.10. Global Pigmentation Disorders Treatment Market, Sub-Segmentation Of Phototherapy, By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • UVB Phototherapy
  • Narrowband UVB Phototherapy
  • 6.11. Global Pigmentation Disorders Treatment Market, Sub-Segmentation Of Other Treatment Types, By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cryotherapy
  • Depigmentation Therapy
  • Microneedling
  • Platelet-Rich Plasma (PRP) Therapy

7. Pigmentation Disorders Treatment Market Regional And Country Analysis

  • 7.1. Global Pigmentation Disorders Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Pigmentation Disorders Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Pigmentation Disorders Treatment Market

  • 8.1. Asia-Pacific Pigmentation Disorders Treatment Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Pigmentation Disorders Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Pigmentation Disorders Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Pigmentation Disorders Treatment Market, Segmentation By Type Of Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Pigmentation Disorders Treatment Market

  • 9.1. China Pigmentation Disorders Treatment Market Overview
  • 9.2. China Pigmentation Disorders Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Pigmentation Disorders Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Pigmentation Disorders Treatment Market, Segmentation By Type Of Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Pigmentation Disorders Treatment Market

  • 10.1. India Pigmentation Disorders Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Pigmentation Disorders Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Pigmentation Disorders Treatment Market, Segmentation By Type Of Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Pigmentation Disorders Treatment Market

  • 11.1. Japan Pigmentation Disorders Treatment Market Overview
  • 11.2. Japan Pigmentation Disorders Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Pigmentation Disorders Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Pigmentation Disorders Treatment Market, Segmentation By Type Of Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Pigmentation Disorders Treatment Market

  • 12.1. Australia Pigmentation Disorders Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Pigmentation Disorders Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Pigmentation Disorders Treatment Market, Segmentation By Type Of Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Pigmentation Disorders Treatment Market

  • 13.1. Indonesia Pigmentation Disorders Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Pigmentation Disorders Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Pigmentation Disorders Treatment Market, Segmentation By Type Of Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Pigmentation Disorders Treatment Market

  • 14.1. South Korea Pigmentation Disorders Treatment Market Overview
  • 14.2. South Korea Pigmentation Disorders Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Pigmentation Disorders Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Pigmentation Disorders Treatment Market, Segmentation By Type Of Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Pigmentation Disorders Treatment Market

  • 15.1. Western Europe Pigmentation Disorders Treatment Market Overview
  • 15.2. Western Europe Pigmentation Disorders Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Pigmentation Disorders Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Pigmentation Disorders Treatment Market, Segmentation By Type Of Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Pigmentation Disorders Treatment Market

  • 16.1. UK Pigmentation Disorders Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Pigmentation Disorders Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Pigmentation Disorders Treatment Market, Segmentation By Type Of Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Pigmentation Disorders Treatment Market

  • 17.1. Germany Pigmentation Disorders Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Pigmentation Disorders Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Pigmentation Disorders Treatment Market, Segmentation By Type Of Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Pigmentation Disorders Treatment Market

  • 18.1. France Pigmentation Disorders Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Pigmentation Disorders Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Pigmentation Disorders Treatment Market, Segmentation By Type Of Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Pigmentation Disorders Treatment Market

  • 19.1. Italy Pigmentation Disorders Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Pigmentation Disorders Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Pigmentation Disorders Treatment Market, Segmentation By Type Of Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Pigmentation Disorders Treatment Market

  • 20.1. Spain Pigmentation Disorders Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Pigmentation Disorders Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Pigmentation Disorders Treatment Market, Segmentation By Type Of Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Pigmentation Disorders Treatment Market

  • 21.1. Eastern Europe Pigmentation Disorders Treatment Market Overview
  • 21.2. Eastern Europe Pigmentation Disorders Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Pigmentation Disorders Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Pigmentation Disorders Treatment Market, Segmentation By Type Of Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Pigmentation Disorders Treatment Market

  • 22.1. Russia Pigmentation Disorders Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Pigmentation Disorders Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Pigmentation Disorders Treatment Market, Segmentation By Type Of Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Pigmentation Disorders Treatment Market

  • 23.1. North America Pigmentation Disorders Treatment Market Overview
  • 23.2. North America Pigmentation Disorders Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Pigmentation Disorders Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Pigmentation Disorders Treatment Market, Segmentation By Type Of Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Pigmentation Disorders Treatment Market

  • 24.1. USA Pigmentation Disorders Treatment Market Overview
  • 24.2. USA Pigmentation Disorders Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Pigmentation Disorders Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Pigmentation Disorders Treatment Market, Segmentation By Type Of Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Pigmentation Disorders Treatment Market

  • 25.1. Canada Pigmentation Disorders Treatment Market Overview
  • 25.2. Canada Pigmentation Disorders Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Pigmentation Disorders Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Pigmentation Disorders Treatment Market, Segmentation By Type Of Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Pigmentation Disorders Treatment Market

  • 26.1. South America Pigmentation Disorders Treatment Market Overview
  • 26.2. South America Pigmentation Disorders Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Pigmentation Disorders Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Pigmentation Disorders Treatment Market, Segmentation By Type Of Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Pigmentation Disorders Treatment Market

  • 27.1. Brazil Pigmentation Disorders Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Pigmentation Disorders Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Pigmentation Disorders Treatment Market, Segmentation By Type Of Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Pigmentation Disorders Treatment Market

  • 28.1. Middle East Pigmentation Disorders Treatment Market Overview
  • 28.2. Middle East Pigmentation Disorders Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Pigmentation Disorders Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Pigmentation Disorders Treatment Market, Segmentation By Type Of Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Pigmentation Disorders Treatment Market

  • 29.1. Africa Pigmentation Disorders Treatment Market Overview
  • 29.2. Africa Pigmentation Disorders Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Pigmentation Disorders Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Pigmentation Disorders Treatment Market, Segmentation By Type Of Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Pigmentation Disorders Treatment Market Competitive Landscape And Company Profiles

  • 30.1. Pigmentation Disorders Treatment Market Competitive Landscape
  • 30.2. Pigmentation Disorders Treatment Market Company Profiles
    • 30.2.1. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Bristol-Myers Squibb Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. L'Oreal S.A. Overview, Products and Services, Strategy and Financial Analysis

31. Pigmentation Disorders Treatment Market Other Major And Innovative Companies

  • 31.1. Bausch Health Companies Inc.
  • 31.2. Bayer AG
  • 31.3. Strides Pharma Science Limited
  • 31.4. Galderma S.A.
  • 31.5. Incyte Corporation
  • 31.6. Dr. Reddy's Laboratories Ltd.
  • 31.7. Laboratories Pierre Fabre
  • 31.8. Glenmark Pharmaceuticals Limited.
  • 31.9. Dermavant Sciences Inc.
  • 31.10. Lumenis Be Ltd.
  • 31.11. Accord Healthcare
  • 31.12. Obagi Medical Products Inc.
  • 31.13. Fotona d.o.o.
  • 31.14. Sesderma SL
  • 31.15. DermaMed Solutions LLC.

32. Global Pigmentation Disorders Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Pigmentation Disorders Treatment Market

34. Recent Developments In The Pigmentation Disorders Treatment Market

35. Pigmentation Disorders Treatment Market High Potential Countries, Segments and Strategies

  • 35.1 Pigmentation Disorders Treatment Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Pigmentation Disorders Treatment Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Pigmentation Disorders Treatment Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제